Furthermore, IGF2BP1 directly bound to and recognized the m6A modification on CPT1A mRNA to maintain its stability, which had been reported to endow BC cells with the potential for metastasis 35, 37. The gene discussed is IGF2BP1; the disease is breast cancer.